Literature DB >> 10585269

The dual specificity protein kinase CLK3 is abundantly expressed in mature mouse spermatozoa.

H Menegay1, F Moeslein, G Landreth.   

Abstract

CLK3, a member of the LAMMER family of dual-specificity protein kinases, is abundantly expressed in the reproductive system of male mice. Specifically, high levels of CLK3 protein expression are found in mature spermatozoa in the testis and epididymis. The majority of the CLK3 protein in the testis is a full-length kinase-containing form, and only a small amount of a catalytically inactive N-terminally truncated splice variant protein product is observed. Within the mature spermatozoa CLK3 is localized to the acrosome and tail. CLK3 is expelled from the sperm following the acrosome reaction and inactivated, likely by degradation by the proteases released by the sperm during the acrosome reaction. The CLK family of kinases has previously been implicated in mRNA splicing; however, the bulk of the CLK3 protein in these cells is located in the cytoplasm, suggesting that CLK3 may have additional roles in the cell. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10585269     DOI: 10.1006/excr.1999.4655

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  8 in total

1.  Alternative splicing modulation by a LAMMER kinase impinges on developmental and transcriptome expression.

Authors:  Sigal Savaldi-Goldstein; Dvora Aviv; Olga Davydov; Robert Fluhr
Journal:  Plant Cell       Date:  2003-04       Impact factor: 11.277

2.  The LAMMER protein kinase encoded by the Doa locus of Drosophila is required in both somatic and germline cells and is expressed as both nuclear and cytoplasmic isoforms throughout development.

Authors:  B Yun; K Lee; R Farkas; C Hitte; L Rabinow
Journal:  Genetics       Date:  2000-10       Impact factor: 4.562

3.  Small-molecule pyrimidine inhibitors of the cdc2-like (Clk) and dual specificity tyrosine phosphorylation-regulated (Dyrk) kinases: development of chemical probe ML315.

Authors:  Thomas C Coombs; Cordelle Tanega; Min Shen; Jenna L Wang; Douglas S Auld; Samuel W Gerritz; Frank J Schoenen; Craig J Thomas; Jeffrey Aubé
Journal:  Bioorg Med Chem Lett       Date:  2013-03-30       Impact factor: 2.823

4.  Structural Basis for the Selective Inhibition of Cdc2-Like Kinases by CX-4945.

Authors:  Joo Youn Lee; Ji-Sook Yun; Woo-Keun Kim; Hang-Suk Chun; Hyeonseok Jin; Sungchan Cho; Jeong Ho Chang
Journal:  Biomed Res Int       Date:  2019-08-18       Impact factor: 3.411

Review 5.  Cdc-Like Kinases (CLKs): Biology, Chemical Probes, and Therapeutic Potential.

Authors:  Paula Martín Moyano; Václav Němec; Kamil Paruch
Journal:  Int J Mol Sci       Date:  2020-10-13       Impact factor: 5.923

6.  CDC2-like (CLK) protein kinase inhibition as a novel targeted therapeutic strategy in prostate cancer.

Authors:  Simon Uzor; Sean R Porazinski; Ling Li; Bethany Clark; Masahiko Ajiro; Kei Iida; Masatoshi Hagiwara; Abdullah A Alqasem; Claire M Perks; Ian D Wilson; Sebastian Oltean; Michael R Ladomery
Journal:  Sci Rep       Date:  2021-04-12       Impact factor: 4.379

7.  Kinase domain insertions define distinct roles of CLK kinases in SR protein phosphorylation.

Authors:  Alex N Bullock; Sanjan Das; Judit E Debreczeni; Peter Rellos; Oleg Fedorov; Frank H Niesen; Kunde Guo; Evangelos Papagrigoriou; Ann L Amos; Suhyung Cho; Benjamin E Turk; Gourisankar Ghosh; Stefan Knapp
Journal:  Structure       Date:  2009-03-11       Impact factor: 5.006

8.  The MADD-3 LAMMER Kinase Interacts with a p38 MAP Kinase Pathway to Regulate the Display of the EVA-1 Guidance Receptor in Caenorhabditis elegans.

Authors:  Serena A D'Souza; Luckshi Rajendran; Rachel Bagg; Louis Barbier; Derek M van Pel; Houtan Moshiri; Peter J Roy
Journal:  PLoS Genet       Date:  2016-04-28       Impact factor: 5.917

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.